ICPMS
Menu
More information
WebinarsAbout usContact usTerms of use
LabRulez s.r.o. All rights reserved. Content available under a CC BY-SA 4.0 Attribution-ShareAlike
Language Čeština

    1. Databases

    1. Industries

    1. Instrumentation

    1. Manufacturer

    1. Author

    1. Content Type

    1. Publication Date

    Applications focused on ICP/MS | LabRulez ICPMS

    Elemental Impurity Analysis in Cutaneous and Transcutaneous Drug Products Using ICP-MS Based on ICHQ3D (R2)

    Applications
    | 2022 | Shimadzu
    ICP/MS
    Instrumentation
    ICP/MS
    Manufacturer
    Shimadzu
    Industries
    Pharma & Biopharma

    Analysis of Artificial Tear Eye Drops For Elemental Impurities

    Applications
    | 2022 | Agilent Technologies
    ICP/MS
    Instrumentation
    ICP/MS
    Manufacturer
    Agilent Technologies
    Industries
    Pharma & Biopharma

    Validating performance of an Agilent ICP‑MS for USP <232>/<233> & ICH Q3D(R2)/Q2(R1)

    Applications
    | 2022 | Agilent Technologies
    ICP/MS
    Instrumentation
    ICP/MS
    Manufacturer
    Agilent Technologies
    Industries
    Pharma & Biopharma

    Analysis of Elemental Impurities in Synthetic Oligonucleotides by ICP-MS

    Applications
    | 2023 | Agilent Technologies
    ICP/MS
    Instrumentation
    ICP/MS
    Manufacturer
    Agilent Technologies
    Industries
    Pharma & Biopharma
    • Prev
    • 1
    • Next
     

    Related content

    ‌

    Virus attacking coccolithophore – marine alga that affects the Earth’s climate

    Su, 19.5.2024
    CEITEC
    ‌

    IOCB Tech has opened Pharmtheon, a high-tech center for new medicines in Prague

    Th, 16.5.2024
    Ústav organické chemie a biochemie AV ČR
    ‌

    In LabRulez CAREER section are open positions that you can be interested in!

    We, 15.5.2024
    LabRulez
    ‌
    Other projects
    Follow us
    More information
    WebinarsAbout usContact usTerms of use
    LabRulez s.r.o. All rights reserved. Content available under a CC BY-SA 4.0 Attribution-ShareAlike